Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger Paredes

Showing results (151-160 of 309) with videos related to

Pageof 31
Sort By:
Public Health in Practice (Oxford, England)|September 14, 2022
A simple new screening tool for diagnosing imported schistosomiasisSilvia Roure, Olga Pérez-Quílez, Xavier Vallès, et al.
Antiviral Therapy|September 9, 2011
Effect of an induction period of pegylated interferon-α2a and ribavirin on early virological response in HIV-HCV-coinfected patients: results from the CORAL-2 studyCristina Tural, Ricard Solà, Núria Pérez Alvarez, et al.
Antiviral Research|October 2, 2010
Dynamic escape of pre-existing raltegravir-resistant HIV-1 from raltegravir selection pressureFrancisco M Codoñer, Christian Pou, Alexander Thielen, et al.
Immunobiology|July 24, 2012
HLA class I protective alleles in an HIV-1-infected subject homozygous for CCR5-Δ32/Δ32Ester Ballana, Eva Riveira-Munoz, Christian Pou, et al.
Scientific Reports|March 24, 2023
Pneumoproteins and biomarkers of inflammation and coagulation do not predict rapid lung function decline in people living with HIVDavid M MacDonald, Sarah Samorodnitsky, Chris H Wendt, et al.
Vaccines|November 25, 2023
Vaccination with an HIV T-Cell Immunogen (HTI) Using DNA Primes Followed by a ChAdOx1-MVA Boost Is Immunogenic in Gut Microbiota-Depleted Mice despite Low IL-22 Serum LevelsAleix Elizalde-Torrent, Alessandra Borgognone, Maria Casadellà, et al.
AIDS (London, England)|April 16, 2014
Highly pathogenic adapted HIV-1 strains limit host immunity and dictate rapid disease progressionJudith Dalmau, Margalida Rotger, Itziar Erkizia, et al.
AIDS (London, England)|March 7, 2025
Noncanonical HIV drug resistance mutations: need to close existing gapsSeth Inzaule, Michael R Jordan, Joseph Fokam, et al.
The European Respiratory Journal|April 14, 2017
The microbiome in respiratory medicine: current challenges and future perspectivesRosa Faner, Oriol Sibila, Alvar Agustí, et al.
The Journal of Infectious Diseases|January 28, 2010
Pre-existing minority drug-resistant HIV-1 variants, adherence, and risk of antiretroviral treatment failureRoger Paredes, Christina M Lalama, Heather J Ribaudo, et al.
Pageof 31

Showing results (151-160 of 309) with videos related to

Sort By:
Pageof 31
Public Health in Practice (Oxford, England)|September 14, 2022
A simple new screening tool for diagnosing imported schistosomiasisSilvia Roure, Olga Pérez-Quílez, Xavier Vallès, et al.
Antiviral Therapy|September 9, 2011
Effect of an induction period of pegylated interferon-α2a and ribavirin on early virological response in HIV-HCV-coinfected patients: results from the CORAL-2 studyCristina Tural, Ricard Solà, Núria Pérez Alvarez, et al.
Antiviral Research|October 2, 2010
Dynamic escape of pre-existing raltegravir-resistant HIV-1 from raltegravir selection pressureFrancisco M Codoñer, Christian Pou, Alexander Thielen, et al.
Immunobiology|July 24, 2012
HLA class I protective alleles in an HIV-1-infected subject homozygous for CCR5-Δ32/Δ32Ester Ballana, Eva Riveira-Munoz, Christian Pou, et al.
Scientific Reports|March 24, 2023
Pneumoproteins and biomarkers of inflammation and coagulation do not predict rapid lung function decline in people living with HIVDavid M MacDonald, Sarah Samorodnitsky, Chris H Wendt, et al.
Vaccines|November 25, 2023
Vaccination with an HIV T-Cell Immunogen (HTI) Using DNA Primes Followed by a ChAdOx1-MVA Boost Is Immunogenic in Gut Microbiota-Depleted Mice despite Low IL-22 Serum LevelsAleix Elizalde-Torrent, Alessandra Borgognone, Maria Casadellà, et al.
AIDS (London, England)|April 16, 2014
Highly pathogenic adapted HIV-1 strains limit host immunity and dictate rapid disease progressionJudith Dalmau, Margalida Rotger, Itziar Erkizia, et al.
AIDS (London, England)|March 7, 2025
Noncanonical HIV drug resistance mutations: need to close existing gapsSeth Inzaule, Michael R Jordan, Joseph Fokam, et al.
The European Respiratory Journal|April 14, 2017
The microbiome in respiratory medicine: current challenges and future perspectivesRosa Faner, Oriol Sibila, Alvar Agustí, et al.
The Journal of Infectious Diseases|January 28, 2010
Pre-existing minority drug-resistant HIV-1 variants, adherence, and risk of antiretroviral treatment failureRoger Paredes, Christina M Lalama, Heather J Ribaudo, et al.
Pageof 31